1.25 mg semaglutide Ozempic (Semaglutide Injection) 0.25mg or 0.5mg — Mountainside Medical related medical problems ACC 2025: Oral Semaglutide Reduces

Some GLP-1 medications show protective effects on the kidneys

References Woodward, M

Periodic cost reassessment identifies optimization opportunities

Novo GLP-1 drug shows less lean mass loss than rivals, study says Eli Lilly's LLY.N GLP-1 drug tirzepatide yields greater weight loss on average than Novo Nordisk's NOVOb.CO semaglutide, but at a greater expense to muscles and connective tissues, according to a study published this week ahead of peer review

Food and Drug Administration (FDA) has approved a new starting dosage regimen for the subcutaneous (under the skin) formulation of Leqembi (lecanemab-irmb), an amyloid beta-directed antibody indicated for the treatment of adult patients with Alzheimer's disease